Hansa Biopharma AB (HNSBF)
3.65
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Hansa Biopharma Total Liabilities (Quarterly): 125.03M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 125.03M |
| June 30, 2024 | 117.61M |
| March 31, 2024 | 113.09M |
| December 31, 2023 | 117.80M |
| September 30, 2023 | 112.98M |
| June 30, 2023 | 108.69M |
| March 31, 2023 | 104.80M |
| December 31, 2022 | 104.05M |
| September 30, 2022 | 93.04M |
| June 30, 2022 | 29.65M |
| March 31, 2022 | 27.45M |
| December 31, 2021 | 28.21M |
| September 30, 2021 | 21.91M |
| June 30, 2021 | 21.96M |
| March 31, 2021 | 18.46M |
| December 31, 2020 | 23.49M |
| September 30, 2020 | 21.00M |
| June 30, 2020 | 8.762M |
| March 31, 2020 | 6.536M |
| December 31, 2019 | 10.85M |
| September 30, 2019 | 6.873M |
| June 30, 2019 | 6.734M |
| March 31, 2019 | 6.774M |
| December 31, 2018 | 9.459M |
| September 30, 2018 | 7.167M |
| Date | Value |
|---|---|
| June 30, 2018 | 6.746M |
| March 31, 2018 | 6.671M |
| December 31, 2017 | 6.084M |
| September 30, 2017 | 3.330M |
| June 30, 2017 | 3.574M |
| March 31, 2017 | 2.920M |
| December 31, 2016 | 2.976M |
| September 30, 2016 | 2.329M |
| June 30, 2016 | 2.487M |
| March 31, 2016 | 1.609M |
| December 31, 2015 | 1.494M |
| September 30, 2015 | 1.177M |
| June 30, 2015 | 1.531M |
| March 31, 2015 | 1.751M |
| December 31, 2014 | 0.5814M |
| June 30, 2014 | 0.7221M |
| December 31, 2013 | 0.8212M |
| June 30, 2013 | 0.432M |
| June 30, 2013 | 0.432M |
| December 31, 2012 | 0.4245M |
| June 30, 2012 | 0.3198M |
| June 30, 2012 | 0.3198M |
| December 31, 2011 | 0.9327M |
| June 30, 2011 | 0.7025M |
| December 31, 2010 | 0.8352M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.536M
Minimum
Mar 2020
125.03M
Maximum
Sep 2024
60.77M
Average
28.93M
Median
Total Liabilities (Quarterly) Benchmarks
| Abliva AB | 0.7797M |
| Oncopeptides AB | 14.80M |
| BioInvent International AB | 8.369M |
| BioArctic AB | 19.09M |
| Camurus AB | 45.05M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 93.30M |
| Shareholders Equity (Quarterly) | -31.73M |
| Debt to Equity Ratio | -2.947 |
| Current Ratio | 2.451 |
| Net Debt Paydown Yield | -1.67% |